A recent study demonstrated that TAF1-32i expression was elevated in XDP patients and female carriers compared with control samples but TAF1-32i expression levels did not distinguish carriers versus affected XDP patients (Al Ali et al., 2021). The gene discussed is TAF1; the disease is X-linked dystonia-parkinsonism.